Navigation Links
Genetic Mutations Boost Prostate Cancer Risk
Date:1/16/2008

These variants plus a family history can increase risk up to tenfold, study suggests,,,,

WEDNESDAY, Jan. 16 (HealthDay News) -- A new blood test that looks at five genetic variants could one day predict the risk of developing prostate cancer, a new study says.

Researchers found that among men with four of the five variants, the risk of prostate cancer is increased 400 percent to 500 percent, compared to men with none of the variants. And if a man has these gene variants and a family history of prostate cancer, his risk of developing the disease increases more than 900 percent.

"There are five genetic variants that have been shown to be associated with prostate cancer risk," said lead researcher Dr. Jianfeng Xu, a professor of epidemiology and cancer biology at Wake Forest University School of Medicine.

For the study, the researchers examined DNA samples from 2,893 men with prostate cancer and compared them with DNA of 1,781 healthy men. All the men participated in a prostate cancer study in Sweden.

The researchers found that each of these common genetic variants was independently associated with prostate cancer risk. The five variants plus a family history of prostate cancer accounted for 46 percent of prostate cancer patients.

The effect of each variant is too small to be useful in predicting the risk for prostate cancer, Xu said. "But if you have four of these variants your risk is increased fourfold, which is something we have never seen before," he said.

The five genetic locations include three on chromosome 8q24, one on chromosome 17q12, and one on chromosome 17q24.3, according to the report, published online Jan. 16 in the New England Journal of Medicine.

When family history of prostate cancer is added to the mix, the results become more striking, Xu said. "Family history is the sixth factor," he said. "For a man with five gene variants and a family history the
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. People with anorexia less likely to be blamed when biology, genetics explained
2. Years-Long Search Unlocks Deadly Genetic Disease
3. Brain imaging and genetic studies link thinking patterns to addiction
4. Human genetic variation -- Sciences Breakthrough of the Year
5. Top10 research advances include studies on genetics and stem cell research, stents
6. Twins study shows genetic basis for face and place recognition
7. Heart attack risk from smoking due to genetics
8. International research collaboration narrows focus on genetic cause of Kawasaki disease
9. Genetics May Boost Mexican-Americans Risk for Alcoholism
10. Studies elucidate genetic links between cancer and schizophrenia
11. Possible genetic predictor for response to lithium augmentation in depressed patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Mutations Boost Prostate Cancer Risk 
Genetic Mutations Boost Prostate Cancer Risk
(Date:5/12/2008)... Allied Healthcare Products,Inc. (Nasdaq: AHPI )...quarter ending March 31 fell 64 percent, from abou...ut $100,000 in the current quarter, or 1 cent per,...about $240,000 compared to the,third quarter of th...osts,this fiscal year eroded margins and profits f...
(Date:5/12/2008)...rt, of System, WASHINGTON, May 12 /PRNewswire-U...VA), the nation,s largest single employer of nurse...its top professionals., "VA nurses are the comp...stem," stated Secretary of Veterans Affairs Dr. Ja...s from the personal, one-on-one interaction,betwee...
(Date:5/12/2008)...Montreal, May 12, 2008 A team of researchers has ...il protects the heart in mice with Duchenne muscul...Des Rosiers from the Universit de Montral and the .... Basil Petrof of the Research Institute of the Mc...tian Deschepper of the Institut de recherches clin...
(Date:5/12/2008)...or the 12 weeks ended March ...ewswire-FirstCall/ -- Matrixx,Initiatives, Inc. (N...pany,that develops and markets products that provi...today announced its financial results for the four... For the fourth quarter ended March 31, 2008, the ...
Breaking Medicine News(10 mins):Health News:Allied Healthcare Net Falls on Manufacturing Delays 2Health News:Allied Healthcare Net Falls on Manufacturing Delays 3Health News:Allied Healthcare Net Falls on Manufacturing Delays 4Health News:Allied Healthcare Net Falls on Manufacturing Delays 5Health News:New approach to protect the hearts of patients with muscular dystrophy 2Health News:New approach to protect the hearts of patients with muscular dystrophy 3Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 2Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 3Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 4Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 5Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 6Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 7Health News:Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year 8
...y of Texas has found that caffeine is often used t.... Sleep apnea is a condition characterized by cess...re infants. However, there is a growing concern ov...culatory system.// Researchers in Texas analyzed t...
...vels of the amino acid homocysteine may increase t... researchers report. It is still too soon to be ce...e the risk of Alzheimer's// and other types of dem...stigating. Prior research has shown that elevated ...
... York, there has been a declining trend in mortali... has increased. Researchers at the University of T...e deadliest form of skin cancer, between 1981 and ...ncrease in cases among men - from 2.0 cases per 15...
...y of Texas, offer some valuable advice on how to m... is essential for healthy bones and teeth, and hel...se. Doctors believe that natural sunlight helps th...of natural sunlight three times a week should be a...
Other Medicine News:Health News:Caffeine reduces infant blood flow 2Health News:High Levels of Protein Linked to Brain Shrinkage 2
(Date:5/9/2008)...swire/ -- Osteoarthritis is a,painful and potentia...million people in the United States. It is caused ...novel investigational pain medication,tapentadol, ...icant relief,for patients with joint-disease pain,...fewer gastrointestinal side effects than those tre...
(Date:5/9/2008)...all/ -- Ardea Biosciences, Inc.,(Nasdaq: RDEA ), ... of,small- molecule therapeutics for the treatment...ng gout, today announced that John W. Beck,has bee...rations and Chief,Financial Officer effective May ...rs shortly thereafter. The Company also reported r...
(Date:5/8/2008)...all/ -- DATATRAK International, Inc.,(Nasdaq: DAT...global,eClinical solutions for the clinical trials...r the first quarter of 2008., For the three month...ately 41% to $2,088,000 and the Company reported a... both a basic and diluted basis. These,results com...
(Date:5/8/2008)...ial of asenapine in the treatment of ...TON, May 8 /- Schering-Plou...an overview of asenapine clinical trials,from the ...Meeting of the,American Psychiatric Association in... involving patients with bipolar I disorder and sc...
Breaking Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7TFAH Applauds Release of CDCs State Specific Public Health Emergency Preparedness Report 12366 1TFAH Applauds Release of CDCs State Specific Public Health Emergency Preparedness Report 12366 2Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 3427 1Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 3427 2Cognitive Impairment Declining in Older Adults 12363 1Cognitive Impairment Declining in Older Adults 12363 2Drinking milk may help ease the pressure 2277 1Drinking milk may help ease the pressure 2277 2
...NESS WIRE)--Apr 12, 2007 - AVEO,Pharmaceuticals, I...scovery and development of novel, targeted cancer ...total of 12 oral and poster,presentations at the A...ual Meeting on April 14-18, 2007, in Los Angeles,...e cancer community the,pioneering oncology researc...
...--The costs of eradicating,poliomyelitis from the ...ort term, are much lower than the long term costs ...n. And a recently developed,monovalent vaccine is ...oliomyelitis than an existing trivalent vaccine. T...line and in an upcoming,issue of The Lancet. , Bot...
Other Medicine Technology:AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 2AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical,Pipeline to Be Featured at AACR 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: